Form 8-K - Current report:
SEC Accession No. 0001193125-19-200528
Filing Date
2019-07-24
Accepted
2019-07-24 07:18:55
Documents
3
Period of Report
2019-07-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d759433d8k.htm 8-K 17374
2 EX-99.1 d759433dex991.htm EX-99.1 43194
3 GRAPHIC g759433g36p02.jpg GRAPHIC 3706
  Complete submission text file 0001193125-19-200528.txt   66871
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 19969205
SIC: 2834 Pharmaceutical Preparations